Mpox Vaccination Demand Wanes

The U.S. Centers for Disease Control and Prevention (CDC) latest report indicates a slowing consumer demand for Mpox vaccinations.

As of November 29, 2022, the CDC data indicates that both the first and second doses of the two-dose Bavarian Nordic JYNNEOS® vaccine are no longer in excessive demand.

Since May 2022, 1,118,639 JYNNEOS vaccine doses have been administered in 57 U.S. Jurisdictions reporting data to the CDC.

Conversely, Mpox vaccinations in Africa are just beginning.

The government of the Republic of Korea announced on November 29, 2022, that it would donate the first batch of the Mpox vaccine to Africa through the Africa Centres for Disease Control and Prevention.

Africa has yet to receive vaccines to stem the spread of Mpox, which remains a serious public health threat in countries where the virus is endemic.